Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Twist Bioscience stock price, quote, forecast and news

TWST
US90184D1000
A2N7L2

Price

42.71
Today +/-
-1.15
Today %
-2.91 %
P

Twist Bioscience stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Twist Bioscience stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Twist Bioscience stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Twist Bioscience stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Twist Bioscience's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Twist Bioscience Stock Price History

DateTwist Bioscience Price
8/12/202442.71 undefined
8/9/202443.97 undefined
8/8/202445.42 undefined
8/7/202444.55 undefined
8/6/202446.24 undefined
8/5/202445.33 undefined
8/2/202442.97 undefined
8/1/202453.05 undefined
7/31/202455.81 undefined
7/30/202455.87 undefined
7/29/202457.44 undefined
7/26/202458.08 undefined
7/25/202457.51 undefined
7/24/202456.05 undefined
7/23/202458.88 undefined
7/22/202456.22 undefined
7/19/202453.90 undefined
7/18/202453.56 undefined
7/17/202456.22 undefined
7/16/202458.66 undefined
7/15/202456.15 undefined

Twist Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Twist Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Twist Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Twist Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Twist Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Twist Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Twist Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Twist Bioscience’s growth potential.

Twist Bioscience Revenue, EBIT and net profit per share

DateTwist Bioscience RevenueTwist Bioscience EBITTwist Bioscience Net Income
2029e782.75 M undefined0 undefined0 undefined
2028e609.45 M undefined-76.09 M undefined-68.9 M undefined
2027e526.22 M undefined-109.65 M undefined-103.35 M undefined
2026e448.53 M undefined-126.49 M undefined-113.74 M undefined
2025e373.7 M undefined-159.79 M undefined-146.54 M undefined
2024e309.98 M undefined-190.45 M undefined-178.51 M undefined
2023245.1 M undefined-201 M undefined-204.6 M undefined
2022203.6 M undefined-234.8 M undefined-217.9 M undefined
2021132.3 M undefined-152.7 M undefined-152.1 M undefined
202090.1 M undefined-117.6 M undefined-139.9 M undefined
201954.4 M undefined-108.9 M undefined-107.7 M undefined
201825.4 M undefined-70.6 M undefined-71.2 M undefined
201710.8 M undefined-58.5 M undefined-59.3 M undefined
20162.3 M undefined-43.7 M undefined-44.1 M undefined

Twist Bioscience Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201620172018201920202021202220232024e2025e2026e2027e2028e2029e
210255490132203245309373448526609782
-400.00150.00116.0066.6746.6753.7920.6926.1220.7120.1117.4115.7828.41
-350.00-130.00-24.0012.9631.1138.6441.3836.33------
-7-13-6728518489000000
-43-58-70-108-117-152-234-201-190-159-126-109-760
-2,150.00-580.00-280.00-200.00-130.00-115.15-115.27-82.04-61.49-42.63-28.13-20.72-12.48-
-44-59-71-107-139-152-217-204-178-146-113-103-680
-34.0920.3450.7029.919.3542.76-5.99-12.75-17.98-22.60-8.85-33.98-
26.626.626.627.539.248.353.956.9000000
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Twist Bioscience Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Twist Bioscience is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20162017201820192020202120222023
55.962.280.8138.1290477.9505336.4
0.72.25.310.825.426.235.544.1
00.10.11.312.34.80
1.21.867.312.331.839.332.1
1.21.53.52.66.28.311.911.7
5967.895.7160.1334.9546.5596.5424.3
14.614.812.320.859.2105.7214.4203.4
00000000
00000000
1.10.90.70.50.318.359.754.5
1.11.11.11.11.122.485.885.8
0.50.95.94.43.49.258.5
17.317.72026.864155.6364.9352.2
76.385.5115.7186.9398.9702.1961.4776.5
00000000
00.010.010.470.791.191.621.66
-80.3-139.6-210.9-318.5-458.5-610.6-828.4-1,033
00100200100500-1,800-800
00000000
-76.6-133.4-201.5152.1336.2580.7789.4623.4
2.32.87.59.84.814.920.114.1
4.65.67.616.425.33750.851.5
0.41.10.90.82.69.619.77.8
00000000
1.402.53.33.31.600
8.79.518.530.33663.190.673.4
144.2209.4298.34.41.4000
00000000
0.20.10.30.225.258.281.379.6
144.4209.5298.64.626.658.281.379.6
153.1219317.134.962.6121.3171.9153
76.585.6115.6187398.8702961.3776.4
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Twist Bioscience provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Twist Bioscience's financial health and stability.

Assets

Twist Bioscience's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Twist Bioscience must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Twist Bioscience after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Twist Bioscience's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20162017201820192020202120222023
-44-59-71-107-139-152-217-204
4556691629
00000000
00-43-25-9-5-1
15621337616164
00000000
00000000
-38-51-66-87-142-112-124-142
-6-6-3-14-9-27-101-27
-33-927-104-114156-23250
-27-330-90-104183-13178
00000000
7-20-2-3-3-10
6265911613073322720
6963881583033292700
---2.00-----
00000000
-2249-3446373-87-90
-44.82-57.89-69.85-102.7-152.13-139.3-226.25-170.25
00000000

Twist Bioscience stock margins

The Twist Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Twist Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Twist Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Twist Bioscience's sales revenue. A higher gross margin percentage indicates that the Twist Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Twist Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Twist Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Twist Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Twist Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Twist Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Twist Bioscience Margin History

Twist Bioscience Gross marginTwist Bioscience Profit marginTwist Bioscience EBIT marginTwist Bioscience Profit margin
2029e36.6 %0 %0 %
2028e36.6 %-12.49 %-11.3 %
2027e36.6 %-20.84 %-19.64 %
2026e36.6 %-28.2 %-25.36 %
2025e36.6 %-42.76 %-39.21 %
2024e36.6 %-61.44 %-57.59 %
202336.6 %-82.01 %-83.48 %
202241.36 %-115.32 %-107.02 %
202139.08 %-115.42 %-114.97 %
202031.85 %-130.52 %-155.27 %
201912.87 %-200.18 %-197.98 %
2018-26.77 %-277.95 %-280.31 %
2017-123.15 %-541.67 %-549.07 %
2016-313.04 %-1,900 %-1,917.39 %

Twist Bioscience Stock Sales Revenue, EBIT, Earnings per Share

The Twist Bioscience earnings per share therefore indicates how much revenue Twist Bioscience has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Twist Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Twist Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Twist Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Twist Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Twist Bioscience Revenue, EBIT and net profit per share

DateTwist Bioscience Sales per ShareTwist Bioscience EBIT per shareTwist Bioscience Earnings per Share
2029e13.44 undefined0 undefined0 undefined
2028e10.47 undefined0 undefined-1.18 undefined
2027e9.04 undefined0 undefined-1.77 undefined
2026e7.7 undefined0 undefined-1.95 undefined
2025e6.42 undefined0 undefined-2.52 undefined
2024e5.32 undefined0 undefined-3.07 undefined
20234.31 undefined-3.53 undefined-3.6 undefined
20223.78 undefined-4.36 undefined-4.04 undefined
20212.74 undefined-3.16 undefined-3.15 undefined
20202.3 undefined-3 undefined-3.57 undefined
20191.98 undefined-3.96 undefined-3.92 undefined
20180.95 undefined-2.65 undefined-2.68 undefined
20170.41 undefined-2.2 undefined-2.23 undefined
20160.09 undefined-1.64 undefined-1.66 undefined

Twist Bioscience business model

Twist Bioscience Corp is a company specializing in the production and applications of synthetic DNA. It was founded in 2013 and is based in San Francisco, California, USA. The company utilizes proprietary technologies to cost-effectively produce high-quality and high-quantity synthetic DNA. The company operates in three business areas: DNA synthesis, biopharmaceuticals, and data storage. The DNA synthesis division is the core of the company and involves the production of synthetic DNA for applications in various industries, including medicine, agricultural science, biotechnology, plastic engineering, and others. The company manufactures customized DNA synthesis products tailored to the needs of its customers, allowing them to accelerate and optimize their research and development projects. Twist Bioscience has also developed a proprietary technology called "Twist Biosensor" that enables rapid and cost-effective analysis of genetic variations. The biopharmaceutical division focuses on the development of therapeutics and diagnostics based on synthetic DNA. Twist Bioscience develops antibodies and proteins that can be used in cancer and immunotherapy, as well as diagnostics. In the data storage field, Twist Bioscience develops solutions for storing large amounts of data on DNA. This technology utilizes the dense and stable structure of DNA to securely and reliably store data in the long term. Twist Bioscience's DNA synthesis products are utilized by researchers, companies, and public institutions in various industries. Customers value not only the wide product portfolio but also the high quality and precision of the products, as well as the speed of order processing. The company operates a number of manufacturing facilities near its customers in Europe and Asia to ensure fast and efficient delivery of its products. This allows Twist Bioscience to have a strong position in the global market. In recent years, the company has achieved significant milestones. In 2018, Twist Bioscience went public and raised a total of $70 million through its IPO. The company has also established partnerships with various other companies and institutions to develop new applications and products. Overall, Twist Bioscience is a growing company specializing in the production and applications of synthetic DNA. With its wide range of high-quality and customized DNA synthesis products, as well as its innovative solutions in the biopharmaceutical and data storage sectors, the company has established a strong market position. Twist Bioscience is one of the most popular companies on Eulerpool.com.

Twist Bioscience SWOT Analysis

Strengths

1. Leading provider of synthetic DNA and gene synthesis services in the market.

2. Strong reputation for high-quality products and customer satisfaction.

3. Broad and diverse customer base across various industries.

4. Extensive knowledge and expertise in synthetic biology and genomics.

Weaknesses

1. Reliance on third-party suppliers for raw materials may affect supply chain stability.

2. Limited presence in international markets, potentially missing out on global opportunities.

3. Vulnerability to changes in government regulations regarding genetic engineering.

Opportunities

1. Increasing demand for synthetic DNA and gene synthesis in various industries.

2. Emerging markets and untapped potential in international expansion.

3. Advancements in biotechnology and genomics present new opportunities for innovation.

Threats

1. Intense competition from other synthetic biology companies in the market.

2. Economic downturns and global market uncertainties may impact customer spending.

3. Legal and ethical concerns surrounding genetic engineering may restrict business growth.

Twist Bioscience Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Twist Bioscience historical P/E ratio, EBIT, and P/S ratio.

Twist Bioscience shares outstanding

The number of shares was Twist Bioscience in 2023 — This indicates how many shares 56.9 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Twist Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Twist Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Twist Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Twist Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Twist Bioscience.

Twist Bioscience latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.78 -0.86  (-10.19 %)2024 Q3
3/31/2024-0.83 -0.79  (5.18 %)2024 Q2
12/31/2023-0.79 -0.75  (5.41 %)2024 Q1
9/30/2023-0.94 -0.81  (13.78 %)2023 Q4
6/30/2023-1.16 -0.78  (32.79 %)2023 Q3
3/31/2023-1.14 -1.04  (9.03 %)2023 Q2
12/31/2022-1.16 -0.74  (35.96 %)2023 Q1
9/30/2022-1.27 -0.91  (28.55 %)2022 Q4
6/30/2022-1.34 -1.08  (19.13 %)2022 Q3
3/31/2022-1.3 -1.13  (13.22 %)2022 Q2
1
2
3

Eulerpool ESG Scorecard© for the Twist Bioscience stock

Eulerpool World ESG Rating (EESG©)

34/ 100

🌱 Environment

11

👫 Social

53

🏛️ Governance

38

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
✅
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees33
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Twist Bioscience list of shareholders

%
Name
Stocks
Change
Date
9.38 % The Vanguard Group, Inc.5,462,510-118,37712/31/2023
8.07 % BlackRock Institutional Trust Company, N.A.4,701,46568,37712/31/2023
6.39 % Artisan Partners Limited Partnership3,723,3051,961,62112/31/2023
6.10 % Nikko Asset Management Co., Ltd.3,551,313-32,1303/31/2024
6.10 % William Blair Investment Management, LLC3,549,874-23,54912/31/2023
5.77 % State Street Global Advisors (US)3,362,215-637,76612/31/2023
3.81 % JPMorgan Asset Management U.K. Limited2,216,074-49,16312/31/2023
3.64 % JP Morgan Asset Management2,117,034-553,51412/31/2023
3.16 % Citadel Advisors LLC1,839,616281,16512/31/2023
3.13 % Millennium Management LLC1,821,238-1,993,37212/31/2023
1
2
3
4
5
...
10

Twist Bioscience Executives and Management Board

Ms. Emily Leproust50
Twist Bioscience Chairman of the Board, Chief Executive Officer (since 2013)
Compensation 8 M
Mr. Patrick Finn53
Twist Bioscience President, Chief Operating Officer
Compensation 5.23 M
Dr. William Banyai69
Twist Bioscience Senior Vice President - Advanced Development, General Manager of Data Storage and Director (since 2013)
Compensation 2.82 M
Ms. Paula Green56
Twist Bioscience Senior Vice President - Human Resources
Compensation 2.49 M
Mr. Dennis Cho53
Twist Bioscience Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer
Compensation 1.96 M
1
2
3
4

Most common questions regarding Twist Bioscience

What values and corporate philosophy does Twist Bioscience represent?

Twist Bioscience Corp represents innovative values and a strong corporate philosophy. With a focus on synthetic biology, the company aims to accelerate breakthroughs in areas like healthcare, sustainability, and data storage. Twist Bioscience believes in the power of DNA synthesis technology to enable a wide range of applications that can transform multiple industries. By providing high-quality, custom DNA synthesis solutions, the company strives to empower researchers, scientists, and industry partners to create novel solutions and drive scientific advancements. Leveraging their expertise in DNA synthesis and bioinformatics, Twist Bioscience Corp is committed to fostering a more sustainable, healthier, and data-driven future.

In which countries and regions is Twist Bioscience primarily present?

Twist Bioscience Corp is primarily present in the United States, with headquarters located in South San Francisco, California. The company also has a strong presence in Europe, specifically in the United Kingdom and Germany. Additionally, Twist Bioscience Corp has expanded its reach into the Asia-Pacific region, with operations in Singapore and China. With a focus on synthetic biology and DNA synthesis, Twist Bioscience Corp is at the forefront of genetic engineering advancements. The company's innovative solutions and partnerships have allowed it to establish a global presence in the biotechnology industry.

What significant milestones has the company Twist Bioscience achieved?

Twist Bioscience Corp has achieved several significant milestones. The company successfully launched the Twist Bioscience Tool Suite, a powerful set of DNA writing tools enabling researchers to generate synthetic DNA at scale. Additionally, Twist Bioscience Corp collaborated with Microsoft and researchers to store and retrieve digital data using DNA. The company also introduced the Twist Bioscience NGS Target Enrichment Solution, revolutionizing next-generation sequencing applications. Furthermore, Twist Bioscience Corp expanded its product portfolio by launching the Twist Human Core Exome Kit, facilitating the comprehensive analysis of genetic variations. These milestones showcase the company's commitment to innovation and its role in advancing genetic research and development.

What is the history and background of the company Twist Bioscience?

Twist Bioscience Corp, a leading company in synthetic biology, was founded in 2013. It aims to revolutionize the way DNA is being synthesized by providing high-quality, custom DNA at scale. The company's innovative silicon platform enables the efficient production of DNA, RNA, and proteins. With a vast portfolio of products and services, Twist Bioscience Corp caters to various industries such as healthcare, pharmaceuticals, agriculture, and industrial chemicals. By leveraging its proprietary technology, the company has secured partnerships with renowned organizations worldwide. Today, Twist Bioscience Corp continues to push the boundaries of synthetic biology, promoting advancements in fields ranging from drug discovery to data storage.

Who are the main competitors of Twist Bioscience in the market?

The main competitors of Twist Bioscience Corp in the market are GenScript Biotech Corporation, Integrated DNA Technologies, and Eurofins Genomics.

In which industries is Twist Bioscience primarily active?

Twist Bioscience Corp is primarily active in the biotechnology and life sciences industries.

What is the business model of Twist Bioscience?

The business model of Twist Bioscience Corp revolves around synthetic biology and DNA synthesis. Twist Bioscience is a leading company specializing in the production and commercialization of synthetic DNA constructs. The company offers comprehensive solutions that enable researchers and industries to leverage the power of DNA synthesis for various applications, including precision medicine, agricultural biotechnology, and industrial chemicals. Twist Bioscience employs a high-throughput silicon-based DNA synthesis platform, empowering scientists to rapidly and cost-effectively create customized genes, antibodies, and other DNA-based products. With its innovative technology and extensive product portfolio, Twist Bioscience Corp aims to drive discovery, accelerate development, and address real-world challenges through advanced synthetic biology solutions.

What is the P/E ratio of Twist Bioscience 2024?

The Twist Bioscience P/E ratio is -13.61.

What is the P/S ratio of Twist Bioscience 2024?

The Twist Bioscience P/S ratio is 7.84.

What is the AlleAktien quality score of Twist Bioscience?

The AlleAktien quality score for Twist Bioscience is 4/10.

What is the revenue of Twist Bioscience 2024?

The expected Twist Bioscience revenue is 309.98 M USD.

How high is the profit of Twist Bioscience 2024?

The expected Twist Bioscience profit is -178.51 M USD.

What is the business model of Twist Bioscience

Twist Bioscience Corp was founded in 2013 in San Francisco and specializes in the production of synthetic DNA strands used in research and biotechnology. Their business model is based on their proprietary synthesis technology, which allows them to produce large quantities of high-quality, customized DNA quickly and cost-effectively. The company offers its products and services in four main areas: 1. DNA synthesis: Twist Bioscience offers a variety of DNA synthesis products used by researchers, companies, and government agencies. They produce synthetic DNA strands in various formats and sizes, including DNA primers, oligonucleotides, gene fragments, and complete genes. 2. Data and information analysis: To effectively work with Twist Bioscience, it is important for customers to analyze and understand the data from their DNA samples. Therefore, the company has developed a platform for data and information analysis that allows customers to process their genetic data quickly and easily. 3. Bio-products: Twist Bioscience has developed a variety of bio-products based on their DNA technology. These products include antibodies, RNA probes, protein A colloids, and other biological reagents. 4. DNA storage: In addition to their DNA production activity, Twist Bioscience has also developed a technology for storing data on synthetic DNA. This method of data storage is designed to enable long-term, secure, and cost-effective storage of large amounts of data. Twist Bioscience has customers worldwide in fields such as biotechnology, pharmaceuticals, diagnostics, agriculture, and the research community overall. It also works closely with government agencies to create solutions for bio-scientific critical applications and meet the growing demands of the market. Through its DNA synthesis products and information analysis, bio-products, and innovative DNA storage technology, Twist Bioscience remains at the forefront of genomics and biotechnology. The company has received several patents and awards, including the "Best Workplace" award from the San Francisco Business Times and the Silicon Valley Business Journal in 2018. Its expanding presence in Asian markets and successful expansion even during the COVID-19 pandemic period are among its key success factors.

What is the Twist Bioscience dividend?

Twist Bioscience pays a dividend of 0 USD distributed over payouts per year.

How often does Twist Bioscience pay dividends?

The dividend cannot currently be calculated for Twist Bioscience or the company does not pay out a dividend.

What is the Twist Bioscience ISIN?

The ISIN of Twist Bioscience is US90184D1000.

What is the Twist Bioscience WKN?

The WKN of Twist Bioscience is A2N7L2.

What is the Twist Bioscience ticker?

The ticker of Twist Bioscience is TWST.

How much dividend does Twist Bioscience pay?

Over the past 12 months, Twist Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Twist Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Twist Bioscience?

The current dividend yield of Twist Bioscience is .

When does Twist Bioscience pay dividends?

Twist Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Twist Bioscience?

Twist Bioscience paid dividends every year for the past 0 years.

What is the dividend of Twist Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Twist Bioscience located?

Twist Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Twist Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Twist Bioscience from 8/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/13/2024.

When did Twist Bioscience pay the last dividend?

The last dividend was paid out on 8/13/2024.

What was the dividend of Twist Bioscience in the year 2023?

In the year 2023, Twist Bioscience distributed 0 USD as dividends.

In which currency does Twist Bioscience pay out the dividend?

The dividends of Twist Bioscience are distributed in USD.

All fundamentals about Twist Bioscience

Our stock analysis for Twist Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Twist Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.